Lifeward (LFWD) CEO Issues Open Letter to Shareholders

Go back to Lifeward (LFWD) CEO Issues Open Letter to Shareholders

Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate

April 1, 2024 4:30 PM EDT

Collaboration with CMS on final payment rate focuses on commercial transaction values for the latest generation of ReWalk Exoskeleton

CMS indicates that recently issued fee schedule which omitted exoskeletons can be updated after April 1 to include the final payment rate once it is established

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward), (Nasdaq: LFWD) (Lifeward or the Company), a global market leader delivering life-changing solutions to revolutionize what is possible in... More